Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,767,284
+$2,306,320 QoQ
Shares Held
8,977
-2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,224
of 4,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CRAWFORD INVESTMENT COUNSEL INC holds $569,205,568 across 10 Drug Manufacturers - General names. LLY ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
818,972 | $206,086,114 | |
| 2 | AZN |
Astrazeneca PLC
|
708,224 | $134,293,434 | |
| 3 | JNJ |
Johnson & Johnson
|
468,190 | $118,906,214 | |
| 4 | PFE |
Pfizer Inc
|
1,735,218 | $41,784,049 | |
| 5 | GSK |
GSK plc
|
634,985 | $33,285,913 | |
| 6 | MRK |
Merck & Co., Inc.
|
144,979 | $18,629,801 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
8,977 | $10,767,284 | |
| 8 | AMGN |
Amgen Inc
|
7,793 | $2,822,001 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,767,284 | 8,977 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,460,964 | 9,199 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,373,887 | 9,653 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,059,276 | 9,252 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,344,731 | 9,422 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,059,878 | 8,548 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,330,400 | 8,200 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,130,045 | 8,048 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,402,386 | 8,176 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,067,310 | 7,799 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,860,969 | 8,339 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,480,201 | 8,341 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,020,096 | 8,572 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,626,819 | 7,649 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,724,410 | 7,447 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,445,496 | 7,563 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,621,399 | 8,085 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,377,443 | 8,302 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,487,637 | 9,006 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,121,039 | 9,180 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,178,144 | 9,490 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,789,922 | 9,581 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,633,527 | 9,675 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $1,361,043 | 9,195 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,517,351 | 9,242 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,320,753 | 9,521 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||